Trial intelligence / Profile preview

JK-5G for Postoperative Gastrointestinal Function Recovery in Malignant Bowel Obstruction

NCT07850089Not yet recruiting

Sponsor
The First Affiliated Hospital of Wenzhou Medical University
Start
Sep 2026
Primary completion
Feb 2028
01

Overview

Randomised, double-blind trial of JK5G in postoperative ileus (POI) (2 arms), sponsored by The First Affiliated Hospital of Wenzhou Medical University. Primary endpoint: Time from surgery end to GI-2 recovery up to 30 days. Planned start Sep 2026; status: not yet recruiting.

02

Drugs

JK5G
03

Conditions

postoperative ileus (POI)

Beyond the preview

Go deeper on NCT07850089.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT07850089.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call